Research Communications

Open forums for Edison Biotechnology Institute Director candidates 

During the week of July 30, the Ohio University community can meet with the candidates for the Edison Biotechnology Institute director position during a series of open forums.

An interdisciplinary research institute established in 1984, the Edison Biotechnology Institute has a dual mission of basic discovery research and development of new technology and the transfer of technology to the private sector for economic benefit in Ohio. The institute’s investigators seek to understand the molecular and genetic basis of diseases that disproportionately affect the people of Appalachian Ohio and that also are major worldwide challenges. Topics under study include growth disorders; diabetes, obesity and related cardiovascular complications; autoimmune/inflammatory diseases; aging; infectious diseases; and cancer. The institute has produced 95 percent of all Ohio University research royalty revenue and has generated eight start-up companies.

David Wight served as director of the institute from 1995 until his retirement in June.

The finalists for the director position are:

•    Shiyong Wu, principal investigator at Edison Biotechnology Institute and professor of chemistry and biochemistry. The open forum will be held from 1 to 2 p.m. on Monday, July 30.

•    Calvin James, associate professor of virology, Heritage College of Osteopathic Medicine. The open forum will be held from 11 a.m. to noon on Thursday, Aug. 2.

All open forums will be held in the auditorium of the Konneker Research Labs, The Ridges.